Real life outcomes of patients aged =75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Salamero O
  • Sobas M
  • Benavente C
  • Vives S
  • De la Serna J
  • Pérez-Encinas M
  • Escoda L
  • Gil C
  • Brunet S
  • Ramos F
  • Esteve J
  • Amigo M
  • Krsnik I
  • Manso F
  • Arias J
  • González-Campos J
  • Serrano J
  • Oleksiuk J
  • Barrios M
  • García-Boyero R
  • Novo A
  • PETHEMA and PALG Groups

Grupos

Abstract

Acute promyelocytic leukemia is infrequent among patients aged =75 years old, a population that is rarely eligible for clinical protocols. This study aims to analyze the treatment strategies and clinical outcomes of very old APL patients reported to the international PETHEMA registry. Between 1997 and 2017, among 2501 APL cases registered 120 were =75 years old. Treatment approaches were: AIDA regimen, 79 patients; ATRA alone, 23; 16, supportive care (SC) and 2, other strategies. Patients treated with AIDA were younger, had better ECOG and lower leukocytes. Complete remission (CR) was achieved in 65% of AIDA-group vs. 45% in the ATRA-group, being infections followed by bleeding the most frequent causes of induction death. Patients in CR after AIDA showed 3-year DFS of 73%. Our real-life series of very old APL patients provides a reference basis for future treatment strategies aiming to improve clinical outcomes in this challenging population.

Datos de la publicación

ISSN/ISSNe:
1042-8194, 1029-2403

LEUKEMIA & LYMPHOMA  TAYLOR & FRANCIS LTD

Tipo:
Article
Páginas:
1-13
PubMed:
31068052
Factor de Impacto:
0,886 SCImago ℠
Cuartil:
Q2 SCImago ℠

Citas Recibidas en Web of Science: 6

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • APL prognostic factors, APL real life outcomes, Elderly APL, induction mortality in APL

Campos de Estudio

Cita

Compartir